Echo IQ said the FDA issued a not substantially equivalent determination for its initial 510(k) application for Echosolv HF, an AI-based heart failure clinical decision support software. The not-SE determination delays U.S. commercial clearance. The development highlights that AI medical devices still face conventional predicate-based scrutiny, and timeline risk remains tied to regulatory comparability rather than purely to model performance metrics.